Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Tecentriq
Pharma
Roche's Vabysmo crosses $4B mark as Polivy joins blockbuster club
Despite 43% year-over-year growth, Vabysmo’s fourth-quarter sales missed analyst expectations by 2%.
Angus Liu
Jan 30, 2025 11:06am
Merck moves a step closer with subcutaneous version of Keytruda
Nov 19, 2024 10:20am
Jazz's almost-withdrawn lung cancer drug shows life
Oct 15, 2024 10:15am
Exelixis plots FDA prostate cancer filing despite survival miss
Sep 16, 2024 5:00pm
Roche's subcutaneous Tecentriq wins FDA nod after delay
Sep 13, 2024 11:41am
Vabysmo soars as Roche grows through COVID sales declines
Feb 1, 2024 11:36am
